Wael Alanazi earned his Bachelor’s degree in Pharmaceutical Sciences from King Saud University in 2011. After graduation, Wael worked for the Drug Sector at Saudi Food and Drug Authority for evaluation of the quality of pharmaceutical products. In 2012, he worked as a teaching assistant in Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University. In 2013, Wael started his doctoral research in Department of Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, USA. He joined Dr. Jackson’s laboratory and completed his thesis in title “The role of recurrent insulin-induced hypoglycemia on renal prostanoids production, (pro)renin receptor expression and oxidative stress in heart and kidney”. In 2016, Wael earned his Ph.D. in Pharmacology and published several peer-reviewed articles. Now, Dr. Wael works as an assistant professor in College of Pharmacy, King Saud University.


Research Interests

  • Identifying novel therapeutic strategies for the prevention of diabetes-induced renal and cardiovascular diseases in various animal models of diabetes.

  • Investigating the roles of renin angiotensin system, cyclooxygenases and oxidative stress in diabetic complications. 

  • Studying the link between blood glucose levels and different vicious pathways causing kidney damage and hypertension in hypoglycemic and/or hyperglycemic animal models.

  • Studying the biochemical and molecular effects of insulin and oral hypoglycemic agents.